![Newly Diagnosed Lung Cancer: Which Molecular Tests Are Needed for Optimal Treatment Decision Making? Newly Diagnosed Lung Cancer: Which Molecular Tests Are Needed for Optimal Treatment Decision Making?](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ac4e837922e0e7d6cf130ab16bc98e587b0847ee-600x439.png/1806how-table1.png?fit=crop&auto=format)
Newly Diagnosed Lung Cancer: Which Molecular Tests Are Needed for Optimal Treatment Decision Making?
![Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1044579X17300974-gr2.jpg)
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect
![Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research](http://www.cjcrcn.org/data/pic/3347_0.png)
Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research
![PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer](https://www.researchgate.net/profile/Joachim-Pawel/publication/242354126/figure/tbl2/AS:393144983146497@1470744476106/Recommendations-for-use-of-markers-according-to-histologies-of-lung-cancer-and_Q320.jpg)
PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer
![Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization - Journal of Thoracic Oncology Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2039850632/2053443895/gr1.jpg)
Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization - Journal of Thoracic Oncology
![Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer - Palmer - Journal of Thoracic Disease Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer - Palmer - Journal of Thoracic Disease](https://cdn.amegroups.cn/journals/pbpc/files/journals/2/articles/2168/public/2168-PB5-R1.png/w300)
Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer - Palmer - Journal of Thoracic Disease
![PDF] Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. | Semantic Scholar PDF] Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/75c7a5a10a62339b88fe5157b0ecc21dd7bfacd8/2-Table3-1.png)
PDF] Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. | Semantic Scholar
Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer | PLOS ONE
![Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies](https://www.frontiersin.org/files/Articles/873994/fonc-12-873994-HTML/image_m/fonc-12-873994-t001.jpg)
Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
![Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution | Nature Communications Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-019-13441-6/MediaObjects/41467_2019_13441_Fig1_HTML.png)
Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution | Nature Communications
![PDF] Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation | Semantic Scholar PDF] Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9f8e3ef5835b350425251c81aa92d6fd5751b05d/2-Table1-1.png)
PDF] Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation | Semantic Scholar
Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer | PLOS ONE
![SciELO - Brasil - Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo SciELO - Brasil - Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo](https://minio.scielo.br/documentstore/1806-3756/QytwY3bdQmckM7Z8zPypmSP/2c61e75018d54ce51fb990b6b1124136d5f9df4e.gif)
SciELO - Brasil - Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo
![Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes - Lung Cancer Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/54551cae-2d1c-4642-9b5f-08a828dbc76a/pl1.jpg)